The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort
Authors
Olsson-Brown, A. C.Baxter, M.
Feeney, L.
Tivey, Ann
Rodgers, L. J.
Mughal, S.
Lee, Rebecca J
Gault, A.
Dobeson, C.
Rowe, M.
Hughes, D. J.
Heseltine, J.
Parikh, S.
Cotton, J.
Salawu, A.
Tinsley, N.
Shotton, R.
Angelakas, A.
Zhao, S.
Jones, C.
Affiliation
Clatterbridge Cancer Centre, LiverpoolIssue Date
2022
Metadata
Show full item recordCitation
Olsson-Brown AC, Baxter M, Feeney L, Tivey A, Rodgers LJ, Mughal S, et al. The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort. Journal of Clinical Oncology. 2022 Jun;40(16). PubMed PMID: WOS:000863680300746.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2022.40.16_suppl.2522Additional Links
https://dx.doi.org/10.1200/JCO.2022.40.16_suppl.2522Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.2022.40.16_suppl.2522